Roger Stupp

  • 41119 Citations
1990 …2023
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1990 2020

Filter
Letter
2019

Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels

Hottinger, A. F., Bensaid, D., De Micheli, R., Moura, B., Mokhtari, K., Cardoso, E., Idbaih, A. & Stupp, R., Jan 1 2019, In : Annals of Oncology. 30, 1, p. 155-156 2 p.

Research output: Contribution to journalLetter

Glioma
Pharmaceutical Preparations
Neoplasms
2018
64 Citations (Scopus)

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Brat, D. J., Aldape, K., Colman, H., Holland, E. C., Louis, D. N., Jenkins, R. B., Kleinschmidt-DeMasters, B. K., Perry, A., Reifenberger, G., Stupp, R., von Deimling, A. & Weller, M., Nov 1 2018, In : Acta Neuropathologica. 136, 5, p. 805-810 6 p.

Research output: Contribution to journalLetter

Astrocytoma
Glioblastoma

Hospital volume and group expertise in newly diagnosed glioblastoma management

Lukas, R. V., Lesniak, M. S. & Stupp, R., Jan 1 2018, In : Journal of Neuro-Oncology. 136, 1, p. 213-214 2 p.

Research output: Contribution to journalLetter

In reply

Stupp, R. & Ram, Z., May 1 2018, In : JAMA - Journal of the American Medical Association. 319, 17, 1 p.

Research output: Contribution to journalLetter

2017

Evidence-based management of adult patients with diffuse glioma – Authors' reply

Weller, M., van den Bent, M., Tonn, J. C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., Henriksson, R., Rhun, E. L., Balana, C., Chinot, O., Bendszus, M., Reijneveld, J. C., Dhermain, F., French, P., Marosi, C., Watts, C., Oberg, I., Pilkington, G., Baumert, B. G., Taphoorn, M. J. B. & 6 others, Hegi, M., Westphal, M., Reifenberger, G., Soffietti, R., Wick, W. & the European Association for Neuro-Oncology (EANO) Task Force on Gliomas, Aug 2017, In : The Lancet Oncology. 18, 8, p. e430-e431

Research output: Contribution to journalLetter

3 Citations (Scopus)

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply

Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., Ashby, L., Mechtler, L., Goldlust, S. A., Iwamoto, F., Drappatz, J., O'Rourke, D. M., Wong, M., Hamilton, M. G., Finocchiaro, G., Perry, J., Wick, W., Green, J., He, Y., Turner, C. D. & 5 others, Yellin, M. J., Keler, T., Davis, T. A., Stupp, R. & Sampson, J. H., Dec 2017, In : The Lancet Oncology. 18, 12, p. e709-e710

Research output: Contribution to journalLetter

Phase III Clinical Trials
Decision Making
2016
5 Citations (Scopus)

Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial

Früh, M., Ris, H. B., Xyrafas, A., Peters, S., Mirimanoff, R. O., Gautschi, O., Pless, M. & Stupp, R., Jan 1 2016, In : Annals of Oncology. 27, 10, p. 1971-1972 2 p.

Research output: Contribution to journalLetter

docetaxel
Local Neoplasm Recurrences
Antineoplastic Combined Chemotherapy Protocols
Preoperative Care
Taxoids

Reply to F. Felix et al and M.F. Fay et al

Happold, C., Gorlia, T., Chinot, O., Gilbert, M. R., Nabors, L. B., Wick, W., Pugh, S. L., Hegi, M., Cloughesy, T., Roth, P., Reardon, D. A., Perry, J. R., Mehta, M. P., Stupp, R. & Weller, M., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 3107-3108 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Treatment for patients with newly diagnosed glioblastoma: In Reply

Stupp, R., Toms, S. A. & Kesari, S., Jun 7 2016, In : JAMA - Journal of the American Medical Association. 315, 21, p. 2348-2349 2 p.

Research output: Contribution to journalLetter

Alkylating Antineoplastic Agents
Maintenance Chemotherapy
Electric Stimulation Therapy
Dacarbazine
Glioblastoma
2014
5 Citations (Scopus)

Addition of lomustine for bevacizumab-refractory recurrent glioblastoma

Tonder, M., Eisele, G., Weiss, T., Hofer, S., Seystahl, K., Valavanis, A., Stupp, R., Weller, M. & Roth, P., Oct 1 2014, In : Acta Oncologica. 53, 10, p. 1436-1440 5 p.

Research output: Contribution to journalLetter

6 Citations (Scopus)

Does cilengitide deserve another chance?-Authors' reply

Stupp, R., Picard, M. & Weller, M., Jan 1 2014, In : The Lancet Oncology. 15, 13, p. e585-e586

Research output: Contribution to journalLetter

DNA Modification Methylases
DNA Repair Enzymes
Tumor Suppressor Proteins
Dacarbazine
Snake Venoms
1 Citation (Scopus)

Reply to M.C. Chamberlain

Gilbert, M. R., Dignam, J., Pugh, S., Armstrong, T. S., Wefel, J. S., Aldape, K., Stupp, R., Hegi, M., Won, M., Curran, W. J. & Mehta, M. P., May 20 2014, In : Journal of Clinical Oncology. 32, 15, p. 1634-1635 2 p.

Research output: Contribution to journalLetter

Alkylating Antineoplastic Agents
Dacarbazine
Glioblastoma
Brain Neoplasms
2012
15 Citations (Scopus)

Personalised medicine in oncology: Questions for the next 20 years

Blay, J. Y., Lacombe, D., Meunier, F. & Stupp, R., May 1 2012, In : The Lancet Oncology. 13, 5, p. 448-449 2 p.

Research output: Contribution to journalLetter

Precision Medicine
Medical Oncology
Neoplasms

Treatment options in elderly patients with glioblastoma - Authors' reply

Malmström, A., Stupp, R., Hegi, M., Rosell, J. & Henriksson, R., Nov 1 2012, In : The Lancet Oncology. 13, 11

Research output: Contribution to journalLetter

Glioblastoma
Therapeutics
2011
4 Citations (Scopus)

Trimodality therapy for locally advanced non-small-cell lung cancer: A curative approach

Stupp, R., Betticher, D., Ris, H. B., Peters, S. & Pless, M., Feb 10 2011, In : Journal of Clinical Oncology. 29, 5

Research output: Contribution to journalLetter

Antineoplastic Combined Chemotherapy Protocols
Dose Fractionation
Combined Modality Therapy
Neoplasm Staging
Non-Small Cell Lung Carcinoma
2010
84 Citations (Scopus)

Bevacizumab and recurrent malignant gliomas: A European perspective

Wick, W., Weller, M., Van Den Bent, M. & Stupp, R., Apr 20 2010, In : Journal of Clinical Oncology. 28, 12, p. e188-e189

Research output: Contribution to journalLetter

Local Neoplasm Recurrences
Antineoplastic Combined Chemotherapy Protocols
Angiogenesis Inhibitors
Evidence-Based Medicine
Glioblastoma
8 Citations (Scopus)

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma [1]

Rossetti, A. O. & Stupp, R., Jan 1 2010, In : Neurology. 74, 16, 1 p.

Research output: Contribution to journalLetter

Glioblastoma
Anticonvulsants
Enzymes

Reply to M.C. Chamberlain

Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P. Y., Pietsch, T., Hicking, C. B., Tonn, J. C., Diserens, A. C., Pica, A., Hermisson, M., Picard, M. & Weller, M., Nov 20 2010, In : Journal of Clinical Oncology. 28, 33

Research output: Contribution to journalLetter

2009
23 Citations (Scopus)

Will integrin inhibitors have proangiogenic effects in the clinic?

Weller, M., Reardon, D., Nabors, B. & Stupp, R., Jul 1 2009, In : Nature Medicine. 15, 7, 1 p.

Research output: Contribution to journalLetter

Pathologic Neovascularization
Snake Venoms
Glioblastoma
Integrins
2007

Informed consent: True information or institutional review board-approved disinformation? [1]

Rossel, M., Burnier, M. & Stupp, R., Dec 20 2007, In : Journal of Clinical Oncology. 25, 36, p. 5835-5836 2 p.

Research output: Contribution to journalLetter

Guideline Adherence
Research Ethics Committees
Informed Consent

In reply [2]

Stupp, R. & Hegi, M. E., Aug 10 2007, In : Journal of Clinical Oncology. 25, 23, p. 3550-3551 2 p.

Research output: Contribution to journalLetter

2005
8 Citations (Scopus)

Treatment of brain tumors

Paulino, A. C., Teh, B. S., Sadeh, M., Ashby, L., LaRocca, R., Ryken, T., Seiter, K., Aiken, R. D., Rutkowski, S., Ottensmeier, H., Pietsch, T., Stupp, R., Hegi, M. E. & DeAngelis, L. M., Jun 2 2005, In : New England Journal of Medicine. 352, 22, p. 2350-2353 4 p.

Research output: Contribution to journalLetter

Alkylating Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
O(6)-Methylguanine-DNA Methyltransferase
Cerebellar Neoplasms
Intraventricular Injections
2002
4 Citations (Scopus)

Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide [4] (multiple letters)

Beauchesne, P., Stupp, R., Ostermann-Kraljevic, S., Dietrich, P. Y. & Mirimanoff, R. O., Jul 15 2002, In : Journal of Clinical Oncology. 20, 14, p. 3180-3181 2 p.

Research output: Contribution to journalLetter

temozolomide
Alkylating Antineoplastic Agents
Central Nervous System Neoplasms
Dacarbazine
Phase II Clinical Trials
2 Citations (Scopus)

Treatment of newly diagnosed glioblastoma multiforme [3] (multiple letters)

Nieder, C., Stupp, R., Ostermann-Kraljevic, S., Dietrich, P. Y., Mirimanoff, R. O., Reardon, D. & Bigner, D. D., Jul 15 2002, In : Journal of Clinical Oncology. 20, 14

Research output: Contribution to journalLetter

Alkylating Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Tenascin
Central Nervous System Neoplasms
Dacarbazine